Financial toxicity of cancer treatment 'an underestimated problem'

March 6, 2018 by Joost Bruysters, University of Twente

Besides side effects such as hair loss and nausea, a great many cancer patients in the US have to deal with stress and anxiety as a consequence of the high costs of their treatment. Pricivel Carrera of the University of Twente in the Netherlands has carried out the first large-scale literature review of the financial toxicity of cancer treatments, until now a relatively unexplored research area. The study is published in CA: A Cancer Journal for Clinicians, the scientific journal with the highest impact factor in the world. Carrera says that the financial toxicity of cancer treatment is an underestimated problem. "Doctors should focus as much on the effectiveness of different treatment options and the patient´s personal situation as they are on the disease and the latest technology, if not more."

The development of new, often expensive, treatments for cancer has created a new side effect: financial toxicity. This is related to the financial burden and distress cancer experience due to their treatment. In the worst-case scenario, patients must literally choose between paying co-payment for medicines or paying rent.

The estimates of the numbers of in the US that have to contend with financial toxicity vary considerably since there is, as yet, no sound definition for it and relatively little research has been carried out in this field. However, with estimates between 28 and 48 per cent and 16 and 73 per cent, depending on the way of measurement, it is clear that it is an enormous problem. Those at high risk for financial toxicity cover low income persons, especially the young(er) females, individuals without (adequate) health insurance and patients who have just started treatments.

Recommendations

Carrera advocates more attention for, and research into, financial , which she calls an underestimated problem. In her opinion, the fact that doctors focus primarily on treating diseases and improving the quality of life is proper but, with the ever-rising costs and prices of new treatments, it is becoming increasingly important to look at whether they are actually effective.

"A new treatment is not necessarily better. Newness does not guarantee clinically meaningful improvement which is what distinguishes a treatment as innovative. When we pay for premium prices, as is the case for new technologies in medicine, we rightfully expect better outcomes for the patient rather than, say, a delay in disease progression by a few days."

She also emphasizes that it is advisable to pay attention to patients' personal circumstances because the possibility of embarking on expensive treatments might just cause new problems or added difficulties for some patients. She therefore advises oncologists in the US to be ready to address concerns of patients with the costs of with new drugs, if not raise the matter of the costs and benefits of new treatments versus existing treatments with them, particularly those in the largest risk groups. "Discussions of this kind may be uncomfortable, if not very difficult, but they are essential. The medical oncologist can also be more alert to signals regarding patients' weak financial positions, based on the records of their patients, and point them in the direction of existing financing possibilities."

Explore further: Out-of-pocket costs exceed what many insured cancer patients expect to pay

Related Stories

Out-of-pocket costs exceed what many insured cancer patients expect to pay

August 10, 2017
A third of insured people with cancer end up paying more out-of-pocket than they expected, despite having health coverage, researchers at the Duke Cancer Institute have found.

'Financial toxicity' can lower cancer patients' quality of life

December 19, 2014
Doctors who treat cancer are vigilant when it comes to the physical side effects of the therapies they prescribe, but financial stress from accumulating medical bills can also weigh on patients' health—even those who have ...

Treatment costs can be another blow to cancer patients

July 27, 2017
(HealthDay)—The emotional and physical costs of cancer can be staggering. But the financial side of cancer is also a great burden, with many patients in the United States struggling to pay for treatment, new research ...

New tool for cancer patients measures the stress of expenses

October 7, 2016
For many patients, the uncertainty and stress that can come with cancer treatment is compounded by what is now known as "financial toxicity," the anxiety and distress that follow health care and medication expenses, often ...

Financial difficulties linked to worse outcomes from cancer treatment

October 11, 2016
Financial difficulties can significantly impact a cancer patient's quality of life during treatment and may even increase their risk of death, according to the results of a pooled analysis presented at the ESMO 2016 Congress ...

AHA: breast cancer patients at increased risk for CV disease

February 1, 2018
(HealthDay)—Due to shared risk factors and impact on heart health from cancer treatment, comprehensive care is necessary for breast cancer patients to optimize both cancer treatment and cardiovascular health, according ...

Recommended for you

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Researchers create novel combination as potential therapy for high-risk neuroblastoma

June 18, 2018
Researchers at VCU Massey Cancer Center in Richmond, Virginia, have identified a promising target to reverse the development of high-risk neuroblastoma and potentially inform the creation of novel combination therapies for ...

Genomics offers new treatment options for infants with range of soft tissue tumors

June 18, 2018
The genetic causes of a group of related infant cancers have been discovered by scientists at the Wellcome Sanger Institute, the University of Wuerzburg and their collaborators. Whole genome sequencing of tumours revealed ...

Standard myelofibrosis drug can awaken 'dormant' lymphoma

June 18, 2018
Most patients with myelofibrosis, a rare chronic disorder of the haematopoietic cells of the bone marrow, benefit from drugs from the JAK2 inhibitor class: symptoms are relieved, survival extended and general quality-of-life ...

Breast cancer researcher warns against online genetic tests

June 18, 2018
We have never been so fascinated by the secrets inside our cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.